                         SEQUENCE LISTING

<110>  Doyle, Robert P
 
<120>  MONOMERIC PEPTIDE MULTI-AGONIST TARGETING THE

<130>  156P600

<150>  62/827,229
<151>  2019-04-01

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  36
<212>  PRT
<213>  Homo sapiens

<400>  1

Tyr Pro Ile Lys Pro Glu Ala Pro Gly Glu Asp Ala Ser Pro Glu Glu 
1               5                   10                  15      


Leu Asn Arg Tyr Tyr Ala Ser Leu Arg His Tyr Leu Asn Leu Val Thr 
            20                  25                  30          


Arg Gln Arg Tyr 
        35      


<210>  2
<211>  34
<212>  PRT
<213>  Homo sapiens

<400>  2

Ile Lys Pro Glu Ala Pro Gly Glu Asp Ala Ser Pro Glu Glu Leu Asn 
1               5                   10                  15      


Arg Tyr Tyr Ala Ser Leu Arg His Tyr Leu Asn Leu Val Thr Arg Gln 
            20                  25                  30          


Arg Tyr 
        


<210>  3
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  3

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly 
            20                  25                  


<210>  4
<211>  39
<212>  PRT
<213>  Homo sapiens

<400>  4

His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


<210>  5
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chimeric peptide

<400>  5

His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Thr Arg Gln Arg Tyr 
        35              


<210>  6
<211>  45
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chimeric peptide

<400>  6

His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Ile Asn Glu 
1               5                   10                  15      


Glu Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro 
            20                  25                  30          


Ser Arg His Tyr Leu Asn Leu Val Thr Arg Gln Arg Tyr 
        35                  40                  45  


<210>  7
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chimeric peptide

<400>  7

His Ser Gln Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Ile Asn Glu 
1               5                   10                  15      


Glu Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Arg His Tyr 
            20                  25                  30          


Leu Asn Leu Val Thr Arg Gln Arg Tyr 
        35                  40      


<210>  8
<211>  45
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chimeric peptide

<400>  8

His Ser Gln Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Ile Asn Glu 
1               5                   10                  15      


Glu Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro 
            20                  25                  30          


Ser Arg His Tyr Leu Asn Leu Val Thr Arg Gln Arg Tyr 
        35                  40                  45  


<210>  9
<211>  47
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chimeric peptide

<400>  9

His Ser Gln Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Arg Tyr Tyr Ala 
            20                  25                  30          


Ser Leu Arg Arg His Tyr Leu Asn Leu Val Thr Arg Gln Arg Tyr 
        35                  40                  45          


<210>  10
<211>  52
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chimeric peptide

<400>  10

His Ser Gln Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Ile Asn Glu 
1               5                   10                  15      


Glu Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro 
            20                  25                  30          


Ser Arg Tyr Tyr Ala Ser Leu Arg Arg His Tyr Leu Asn Leu Val Thr 
        35                  40                  45              


Arg Gln Arg Tyr 
    50          


<210>  11
<211>  44
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  chimeric peptide

<400>  11

His Ser Gln Gly Thr Phe Thr Ser Asp Leu Ser Lys Tyr Leu Glu Glu 
1               5                   10                  15      


Glu Ala Val Arg Glu Phe Ile Ala Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30          


Arg His Tyr Leu Asn Leu Val Thr Arg Gln Arg Tyr 
        35                  40                  


